Armed robbery in Revesby8h
First-Ever Drug Cuts Heart Attacks, Strokes in Diabetes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Breakthrough medication significantly cuts risk of heart attacks and strokes: Lancet study
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
Rolling Out20h
Diabetes drugs show promise in reducing COPD complications
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Science Daily20h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Daily23h
Consensus on Peri-Op Management of GLP-1, GIP, & SGLT-2 Inhibitors released
UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...